EdiGENE Competitors and Similar CompaniesClear all

EdiGENE's competitors and similar companies include Maze Therapeutics and Pluri Biotech.

	EdiGENE EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).	Maze Therapeutics Maze Therapeutics is a clinical-stage biopharmaceutical company.	Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
Founding Date	Founding Date 2015	Founding Date 2018	Founding Date 2003
Type	Type Private	Type Public	Type Public
Tags	Tags Technology biotech genetics platform therapy	Tags Technology biotech drug development genetics pharma platform therapy	Tags Technology biotech platform therapy
Locations	Locations Cambridge, US HQ	Locations South San Francisco, US HQ Redwood City, US South San Francisco, US	Locations Haifa, IL HQ Potsdam, DE
Employees	Employees 49	Employees 121	Employees 106
Financial
Cost of goods	Cost of goods N/A	Cost of goods $6.3m (FY, 2025)	Cost of goods $682k (FY, 2025)
Net income	Net income N/A	Net income ($131.1m) (FY, 2025)	Net income ($23.3m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 143.5m	Total funding raised $ 191m	Total funding raised $ 78.4m